Gepato-gastroeterologik tadqiqotlar jurnali 2022, №2

Maqola mavzusi



Ашурова М.Ж., Гарифулина Л.М.


Самарқанд давлат тиббиёт университети


Ушбу адабиётлар шарҳида, болаларда витамин Д етишмовчилиги, унинг семизлик ва бошқа соматик патологиялар ривожланишида тутган ўрни ҳақида ёритилган. Болалар ва ўсмирларда витамин Д дефицити тарқалиш даражаси ҳақида маълумотлар, семиз болаларда витамин Д етишмовчилиги ривожланишининг хавф омиллари ва патогенези. Шу билан биргаликда витамин Д коррекциясининг, семизликда ва бошқа моддалар алмашинуви бузилишида, ўтказилиш усуллари кўрсатилган.

Kalit so'zlar

Болаларда семизлик, витамин Д, витамина Д дефицитининг коррекцияси.


Annweiler C, Schott AM. Dietary intake of vitamin D and cognition in older women: A large population-based study. Neurology. 2010; 75 (20): 1810–1816. 2. Arunabh S., Pollak S., Yeh J. et al. Body fat content and 25-hydroxyvitamin D levels in healthy women // J Clin Endocrinol Metab. – 2003. – № 88. – Р. 157–161. 3. Bеghin L, Huybrechts I, Vicente-Rodriguez G, et al. Main characteristics and participation rate of European adolescents included in the HELENA study. Arch. Public Health. 2012; 70 (1): 14. doi: 10.1186/0778-7367-70-14. 4. Bordelon P., Ghetu M., Langan R. Recognition and management of vitamin D deficiency // Am Fam Physician. – 2009. – № 80 (8). – Р. 841–846. 5. Bischoff-Ferrari H. Vitamin D: what is an adequate vitamin D level and how much supplementation is nessesary? // Best Pract Res Clin Rheumatol. – 2009. –№ 23(6). – Р. 789–795. 6. Bukoski R.D., Xue H., McCarron D.A. Effect of 1,25(OH)2 vi¬tamin D3 and ionized Ca2 uptake by primary cultures of aor¬tic myocytes of spontaneously hypertensive and Wistar Kyoto normotensive rats. Biochem Biophys Res Commun 1987; 146: 1330–1335. 7. Cannell J., Hollis B., Zasloff M. et al. Diagnosis and treatment of vitamin D deficiency// Expert Opin Pharmacother 2008. – № 9. – Р. 107–118. 8. Cannell J., Hollis B. Use of vitamin D in clinical practice // Alternative MedicineReview. – 2008. – № 13. – Р. 6–20. 9. Chapuy M., Preziosi P., Maamer M. et al. Prevalence of vitamin D insufficiency in an adult normal population // Osteoporos. – 1997. – № 7. – Р. 439–443. 10. Davidson MB1, Duran P, Lee ML, Friedman TC. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care. 2013 Feb;36(2):260-6. 11. Davies PD. A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis. Tubercle. 1985; 66 (4): 301–306. 12. Gallicchio L, Helzlsouer KJ, Chow WH, et al. Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consort МЕm Vitamin D Pooling Project of Rarer Cancers. Am. J. Epidemiol. 2010; 172 (1): 10–20. 13. Kulie T., Groff A., Redmer J. et al. Vitamin D: an evidence-based review // JABFM. –2009. – № 22(6). – Р. 698–706. 14. Koutkia P, Chen TC, Holick MF. Vitamin D Intoxication Associated with an Over-the-Counter Supplement. N. Engl. J. Med. 2001; 345 (1): 66–67. 15. Kumar J, Muntner P, Kaskel FJ, Hailpern SM. Prevalence and associations of 25-hydroxyvitamind D deficiency in US children: NHANES 2001–2004. Pediatrics. 2009; 124: 362–370. 16. Lagunova Z., Porojnicu A., Lindberg F., Hexeberg S., Moan J. The dependency of vitamin D status on body mass index, gender, age and season //Anticancer Res. – 2009. – № 29(9). – Р. 3713–20. 17. Li Y.C., Kong J., Wei M. 1,25-Dihydroxyvitamin ( D)3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110: 229–238. 18. Merke J., Hofmann W., Goldschmidt D., Ritz E. Demonstra¬tion of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro. Calcif Tissue Int 1987; 41: 112–114. 19. Merke J., Milde P., Lewicka A. Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthe¬sis of 1,25-dihydroxy-vitamin D3: studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest 1989; 83: 1903–1915. 20. Motiwalaa S.R., Wang T.J. Vitamin D and cardiovascular risk. Current Hypertens Rep 2012; 14(3): 209–218. DOI: 10.1007/ s11906-012-0262-y 21. Maxwell CS, Wood RJ. Update on vitamin D and type 2 diabetes. Nutr Rev. 2011;69(5):291. 22. Munns C, Zacharin MR, Rodda CP, Batch JA, Morley R, Cranswick NE, Craig ME, Cutfield WS, Hofman PL, Taylor BJ, Grover SR, Pasco JA, Palm TA. The geographical distribution and etiology of rickets. Practitioner. 1890; 45: 270–342. 23. Mikirova NA, Belcaro G, Jackson JA, Riordan NH. Vitamin D concentrations, endothelial progenitor cells, and cardiovascular risk factors. Panminerva Med. 2010; 52 (2) (Suppl. 1): 81–87. 24. MacLaughlin J., Holick M. Aging decreases the capacity of human skin to produce vitamin D3 // J Clin Invest. – 1985. – № 76. – Р. 1536–1538. 25. Need A., Morris H., Horowitz M. et al. Effects of skinthikness, age, body fat, and sunlight on serum 25-hydroxyvitamin D // Am J Clin Nutr. – 1993. – № 58. – Р. 882–885 26. Nader NS, Aguirre Castaneda R, Wallace J. Effect of Vitamin D3 Supplementation on Serum 25(OH)D, Lipids and Markers of Insulin Resistance in Obese Adolescents: A Prospective, Randomized, Placebo-Controlled Pilot Trial. Horm Res Paediatr. 2014. Jul 16:107-112. 27. O’Connell T.D., Giacherio D.A., Jarvis A.K., Simpson R.U. In¬hibition of cardiac myocyte maturation by 1,25-dihydroxyvi¬tamin D3. Endocrinology 1995; 136: 482–488. 28. O’Connell T.D., Berry J.E., Jarvis A.K. 1,25-Dihydroxyvita¬min D3 regulation of cardiac myocyte proliferation and hy¬pertrophy. Am J Physiol 1997; 272: H1751–H1758. 29. Oh J., Weng S., Felton S.K., Bhandare S., Riek A., Butler B. et al. 1,25(OH)2 Vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009; 120: 687–698. DOI: 10.1161/CIRCULATIONAHA.109.856070 30. Pourdjabbar A., Dwivedi G., Haddad H. The role of vitamin D in chronic heart failure. Curr Opin Cardiol 2013; 28: 216– 222. DOI: 10.1097/HCO.0b013e32835bd480 31. Radhakishun NN, van Vliet M. Efficacy and Tolerability of a High Loading Dose (25,000 IU Weekly) Vitamin D3 Supplementation in Obese Children with Vitamin D Insufficiency/Deficiency. Horm Res Paediatr. 2014 Jul 19:103-106. 32. Rodriguez-Rodriguez E, Ortega RM, Gonzalez-Rodriguez LG, Lopez-Sobaler AM; UCM Research Group VALORNUT (920030). Vitamin D deficiency is an independent predictor of elevated triglycerides in Spanish school children. Eur. J. Nutr. 2011; 50 (5): 373–378. 33. Rigby W.F., Denome S., Fanger M.W. Regulation of lym¬phokine production and human T lymphocyte activation by 1,25-dihydroxvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest 1987; 79: 1659–1664. 34. Somjen D., Weisman Y., Kohen F. 25-Hydroxyvitamin D3-1-alpha-hydroxy-lase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hor¬mone and estrogenic compounds. Circulation 2005; 111: 1666–1671. DOI: 10.1161/01.CIR.0000160353.27927.70. 35. Walker JP, Hiramoto JS. Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal disease. J. Vasc. Surg. 2014 Jul;60(1):176-83. 36. Worthman J., Matsuoka L., Chen T. et al. Decreased bioavaillability of vitamin D in obesity // Am J Clin Nutr. – 2000, 72. – Р. 690–693. 37. Witham MD, Dove FJ, Dryburgh M. The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia. 2010;53(10):2112-9. 38. Yesiltepe MG, Ozsu E, Kalaca S. Evaluation of Vitamin D Supplementation Doses during Pregnancy in a Population at High Risk for Deficiency. Horm Res Paediatr. 2014;81(6):402-8. 39. Громова О.А., Торшин И.Ю., «Витамины и минералы: между Сциллой и Харибдой», 2012, Москва, 674 С. 40. Zanello S.B., Collins E.D., Marinissen M.J. Vitamin D recep¬tor expression in chicken muscle tissue and cultured myo¬blasts. Horm Metab Res 1997; 29: 231–236. 41. Электрон ресурс. URL: events/nnualmtgdirectory/Documents/AACC_12_Abstracts_ B39-B117.pdf (В-75)